Home > Technical section > Biotechnology > Biotech companies > Illumina


Wednesday 10 February 2010


- Illumina Says ’Significant Growth’ in Sequencing Demand Drove 12-Percent Rise in Q4 Revenue. The company said it is in discussions with several large genome centers about replacing their Genome Analyzers with the newly launched HiSeq 2000, but stressed it is premature to forecast how many customers will opt to trade up. GenomeWeb, February 09, 2010